Syndax Pharmaceuticals SNDX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's change in AP?
- Syndax Pharmaceuticals (SNDX) reported change in AP of -$5.74M in Q1 2026.
- How has Syndax Pharmaceuticals's change in AP changed year-over-year?
- Syndax Pharmaceuticals's change in AP decreased by 263.3% year-over-year, from -$1.58M to -$5.74M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.